Pratap Sandhu, CEO of The Precision Peptide Company, commented: "This is the product that brings peptides into the mainstream
however, over the years, our body's ability to produce glutathione diminishes
If denied, appeal immediately
On December 20, 2024, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. AASM.org Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. NIH study Can the makers of these new weight loss medications really claim to treat and cure Obstructive Sleep Apnea (OSA)
PMID: 40573323
Supports stress resilience